Healthcare Market Research Reports & Industry Analysis

Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.

Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.

The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.

Publications found: 69,648
Sort by:

Dystrophic Epidermolysis Bullosa Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2034

US$ 6,499.00

The 7 major dystrophic epidermolysis bullosa markets reached a value of US$ 525.8 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,857.8 Million by 2034, exhibiting a growt...

May 2024 132 pages

Eczema Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major eczema markets reached a value of US$ 16.8 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 37.1 Billion by 2034, exhibiting a growth rate (CAGR) of 7.46% during...

May 2024 136 pages

Edward’s Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Edward’s syndrome markets reached a value of US$ 3.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 7.6 Billion by 2034, exhibiting a growth rate (CAGR) of 7.51...

May 2024 128 pages

EGFR Inhibitors-Induced Skin Disorders Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major EGFR inhibitors-induced skin disorders markets are expected to exhibit a CAGR of 17.89% during 2024-2034. The EGFR inhibitors-induced skin disorders market has been comprehensively analyze...

May 2024 135 pages

Ehlers-Danlos Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Ehlers-Danlos syndrome markets are expected to exhibit a CAGR of 3.42% during 2024-2034. The Ehlers-Danlos syndrome market has been comprehensively analyzed in IMARC's new report titled 'E...

May 2024 138 pages

Emesis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major emesis markets are expected to exhibit a CAGR of 4.18% during 2024-2034. The emesis market has been comprehensively analyzed in IMARC's new report titled 'Emesis Market: Epidemiology, Indu...

May 2024 140 pages

Emphysema Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major emphysema markets reached a value of US$ 3.2 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 4.9 Billion by 2034, exhibiting a growth rate (CAGR) of 3.84% during...

May 2024 137 pages

Encephalitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major encephalitis markets reached a value of US$ 15.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 23.4 Billion by 2034, exhibiting a growth rate (CAGR) of 4.1% du...

May 2024 137 pages

End-Stage Renal Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major end-stage renal disease markets reached a value of US$ 76.6 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 218.2 Billion by 2034, exhibiting a growth rate (CAGR...

May 2024 137 pages

Endocarditis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major endocarditis markets are expected to exhibit a CAGR of 4.22% during 2024-2034. The endocarditis market has been comprehensively analyzed in IMARC's new report titled 'Endocarditis Market:...

May 2024 131 pages

Endometrial Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major endometrial cancer markets reached a value of US$ 20.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 29.5 Billion by 2034, exhibiting a growth rate (CAGR) of 3...

May 2024 133 pages

Eosinophilia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major eosinophilia markets reached a value of US$ 289.1 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 474.5 Million by 2034, exhibiting a growth rate (CAGR) of 4.61%...

May 2024 131 pages

Eosinophilic Esophagitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major eosinophilic esophagitis markets reached a value of US$ 896.3 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 7,604.7 Million by 2034, exhibiting a growth rate (...

May 2024 137 pages

Ependymoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major ependymoma markets are expected to exhibit a CAGR of 4.03% during 2024-2034. The ependymoma market has been comprehensively analyzed in IMARC's new report titled 'Ependymoma Market: Epidem...

May 2024 131 pages

Epidermolysis Bullosa Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major epidermolysis bullosa markets reached a value of US$ 2,596.3 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3,929.8 Million by 2034, exhibiting a growth rate (C...

May 2024 131 pages

Epithelial Ovarian Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major epithelial ovarian cancer markets reached a value of US$ 2.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 14.3 Billion by 2034, exhibiting a growth rate (CAGR...

May 2024 134 pages

Erdheim-Chester Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Erdheim-Chester disease markets are expected to exhibit a CAGR of 7.13% during 2024-2034. The Erdheim-Chester disease market has been comprehensively analyzed in IMARC's new report titled...

May 2024 135 pages

Erectile Dysfunction Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major erectile dysfunction markets reached a value of US$ 1.9 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.9 Billion by 2034, exhibiting a growth rate (CAGR) of 6...

May 2024 133 pages

Erosive Esophagitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major erosive esophagitis markets are expected to exhibit a CAGR of 19.2% during 2024-2034. The erosive esophagitis market has been comprehensively analyzed in IMARC's new report titled 'Erosive...

May 2024 129 pages

Erythema Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major erythema markets are expected to exhibit a CAGR of 4.38% during 2024-2034. The erythema market has been comprehensively analyzed in IMARC's new report titled 'Erythema Market: Epidemiology...

May 2024 137 pages

Erythromelalgia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major erythromelalgia markets reached a value of US$ 1.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.8 Billion by 2034, exhibiting a growth rate (CAGR) of 4.94%...

May 2024 132 pages

Esophageal Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major esophageal cancer markets reached a value of US$ 9.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 16.5 Billion by 2034, exhibiting a growth rate (CAGR) of 5.7...

May 2024 137 pages

Esophageal Motility Disorders Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major esophageal motility disorders markets are expected to exhibit a CAGR of 5.93% during 2024-2034. The esophageal motility disorders market has been comprehensively analyzed in IMARC's new re...

May 2024 130 pages

Esophageal Squamous Cell Carcinoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major esophageal squamous cell carcinoma markets are expected to exhibit a CAGR of 8.1% during 2024-2034. The esophageal squamous cell carcinoma market has been comprehensively analyzed in IMARC...

May 2024 133 pages

Ewing’s Sarcoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major ewing’s sarcoma markets reached a value of US$ 47.8 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 74.5 Million by 2034, exhibiting a growth rate (CAGR) of 4.1%...

May 2024 135 pages

Exanthema Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major exanthema markets reached a value of US$ 1.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.4 Billion by 2034, exhibiting a growth rate (CAGR) of 5.32% during...

May 2024 134 pages

Exocrine Pancreatic Insufficiency Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major exocrine pancreatic insufficiency markets reached a value of US$ 2.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 4.0 Billion by 2034, exhibiting a growth rat...

May 2024 128 pages

Extensive-Stage Small Cell Lung Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major extensive-stage small cell lung cancer markets are expected to exhibit a CAGR of 7.6% during 2024-2034. The extensive-stage small cell lung cancer market has been comprehensively analyzed...

May 2024 131 pages

Failed Back Surgery Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major failed back surgery syndrome markets reached a value of US$ 13.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 19.6 Billion by 2034, exhibiting a growth rate (...

May 2024 129 pages

Fallopian Tube Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major fallopian tube cancer markets are expected to exhibit a CAGR of 6.96% during 2024-2034. The fallopian tube cancer market has been comprehensively analyzed in IMARC's new report titled 'Fal...

May 2024 132 pages

Familial Adenomatous Polyposis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major familial adenomatous polyposis markets are expected to exhibit a CAGR of 4.23% during 2024-2034. The familial adenomatous polyposis market has been comprehensively analyzed in IMARC's new...

May 2024 138 pages

Familial Mediterranean Fever Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major familial Mediterranean fever markets are expected to exhibit a CAGR of 4.31% during 2024-2034. The familial Mediterranean fever market has been comprehensively analyzed in IMARC's new repo...

May 2024 134 pages

Familial Primary Pulmonary Hypertension Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major familial primary pulmonary hypertension markets reached a value of US$ 5.1 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 8.2 Billion by 2034, exhibiting a grow...

May 2024 133 pages

Fanconi Anemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Fanconi anemia markets reached a value of US$ 49.2 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 78.8 Million by 2034, exhibiting a growth rate (CAGR) of 4.38%...

May 2024 134 pages

Febrile Neutropenia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major febrile neutropenia markets reached a value of US$ 10.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 16.3 Billion by 2034, exhibiting a growth rate (CAGR) of...

May 2024 131 pages

Fecal Incontinence Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major fecal incontinence markets reached a value of US$ 2.1 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.2 Billion by 2034, exhibiting a growth rate (CAGR) of 3.8...

May 2024 140 pages

Female Infertility Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major female infertility markets reached a value of US$ 2.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.7 Billion by 2034, exhibiting a growth rate (CAGR) of 2.7...

May 2024 129 pages

Fibrodysplasia Ossificans Progressiva Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major fibrodysplasia ossificans progressiva markets reached a value of US$ 361.2 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 503.8 Million by 2034, exhibiting a gr...

May 2024 138 pages

Fibromyalgia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major fibromyalgia markets reached a value of US$ 2.2 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.0 Billion by 2034, exhibiting a growth rate (CAGR) of 2.69% dur...

May 2024 135 pages

Filariasis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major filariasis markets are expected to exhibit a CAGR of 7.92% during 2024-2034. The filariasis market has been comprehensively analyzed in IMARC's new report titled 'Filariasis Market: Epidem...

May 2024 139 pages

Focal Segmental Glomerulosclerosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major focal segmental glomerulosclerosis markets reached a value of US$ 332.8 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 578.0 Million by 2034, exhibiting a growt...

May 2024 135 pages

Follicular Lymphoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major follicular lymphoma markets reached a value of US$ 1.6 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.2 Billion by 2034, exhibiting a growth rate (CAGR) of 3....

May 2024 129 pages

Food Allergy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major food allergy markets reached a value of US$ 2,199.4 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3,425.2 Million by 2034, exhibiting a growth rate (CAGR) of 4...

May 2024 134 pages

Fragile X Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Fragile X syndrome markets reached a value of US$ 43.1 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 66.9 Million by 2034, exhibiting a growth rate (CAGR) of 4...

May 2024 136 pages

Friedreich's Ataxia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Friedreich's ataxia markets reached a value of US$ 600.5 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,710.7 Million by 2034, exhibiting a growth rate (CAGR)...

May 2024 131 pages

Frontotemporal Dementia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major frontotemporal dementia markets reached a value of US$ 123.8 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 596.3 Million by 2034, exhibiting a growth rate (CAG...

May 2024 138 pages

Fuchs Dystrophy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Fuchs dystrophy markets reached a value of US$ 148.3 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 292.9 Million by 2034, exhibiting a growth rate (CAGR) of 6....

May 2024 131 pages

Functional Dyspepsia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major functional dyspepsia markets reached a value of US$ 2.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.1 Billion by 2034, exhibiting a growth rate (CAGR) of 3...

May 2024 135 pages

Functional Neurological Disorder Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major functional neurological disorder markets reached a value of US$ 10.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 23.1 Billion by 2034, exhibiting a growth ra...

May 2024 130 pages

Fungal Lung Diseases Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major fungal lung diseases markets are expected to exhibit a CAGR of 3.07% during 2024-2034. The fungal lung diseases market has been comprehensively analyzed in IMARC's new report titled 'Funga...

May 2024 128 pages

Filters

Search

Categories

790
26
203
153
137
134
125
90
65,573
803
720
771
123

Publishers

179
1
158
389
103
453
148
425
3
202
3
6
1,620
487
76
123
208
1,842
111
25
212
1,049
370
23
40
68
472
277
34
29,954
248
501
3,036
1
1
2
3
16
239
536
361
1
1,357
60
1,696
8
8,921
2,215
4,532
321
66
3
36
200
29
29
143
42
83
3
281
85
20
6
43
14
1
178
48
359
36
44
10
11
18
168
297
8
3
18
58
900
6
89
13
24
15
1,285
227
128
386
3
74
10
119
231
46
474
25
133
4

Regions

92
58
45
43
41
31
30
30
29
28
28
28
21
16
16
16
14
12
12
10
10
10
9
8
8
8
7
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
6
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
787
495
2
2
2
117
191
102
53
23
700
26
133
522
174
622
64,679

Price

Date

Pages

Offers

1
280
1
1